Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
about
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadTrends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLNon-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsOutcomes for children and adolescents with cancer: challenges for the twenty-first century.An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.Burkitt lymphoma: pathogenesis and immune evasion.Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.Pediatric lymphomas and histiocytic disorders of childhoodAutologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.Burkitt's lymphoma successfully treated in pregnancy.Primary follicular lymphoma of the testis in children and adolescentsOutcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.International Pediatric Non-Hodgkin Lymphoma Response Criteria.Revised International Pediatric Non-Hodgkin Lymphoma Staging System.Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingPrimary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report.Advances in paediatric cancer treatmentOutcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyCyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.Low-intensity therapy in adults with Burkitt's lymphoma.Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood.Burkitt lymphoma in adults.Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country.Risk-adapted stratification for optimally intensive treatment assignment of pediatric patients with non-Hodgkin lymphoma is an effective strategy in developing countries.Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.Pediatric non-Hodgkin lymphomas: first report from Central Africa.Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.A step towards the cure of Burkitt's lymphoma in developing countriesOutcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.
P2860
Q26797513-66129037-A6D2-400B-AA56-DBEE4595EC7CQ30540646-81BAAD78-87EC-4BA4-92E6-E0FA9B1CED57Q33709463-B197633F-62C8-48A3-B742-2C3CACC5DCF6Q33822062-53557069-2D18-4B25-877E-EDE742909630Q33897659-6A2DAAE8-BEB8-4B53-A03D-AB2927F69061Q34020070-F51FC3DF-2B38-414A-A796-1136B40301C0Q34025468-B9468A6B-3899-4790-938B-6A07AE28FB67Q34189497-F1B0CEDD-4740-4B1C-B5E1-B7BCC6CA020CQ34334050-B57C746F-DC1E-4238-AEF4-1A5B660CF8CFQ34386029-A595A002-7D14-405B-8E64-B2688EAE7BEDQ34605894-E25BF179-9945-4B95-9257-D3A21D01F8F4Q34773043-9E7957F4-4D64-463A-8032-3E4E0D432B1DQ35011933-1EC9240C-96CA-447E-AFC9-4680FD737BEFQ35244347-A9CE2F75-7575-48DD-935D-6EC56AF3F0F4Q35653634-56483ECD-9965-4645-BADD-B95DE3FFB669Q35669884-C59429DF-EC06-48DB-A9F0-2CEBC84A5107Q35708769-131B4AA2-6291-4A5F-A2D3-BCB2B8D11B89Q35708778-753B32EB-A210-4341-8B67-9CBCE75F30ADQ35909668-155BF64A-09D3-495B-B251-543DC90D47CCQ35918343-7653DE8E-A61B-4DC8-B7C4-4ED210835633Q36508630-E74FB8E5-D0B1-4962-805E-D28DD5AC2C82Q36529482-00AF73F4-78E4-421E-9F4A-DDFBB8F3C8B4Q36652629-30D5BF2A-49FF-4219-BC03-ED620B602BD6Q37511989-ED54FC38-CD4E-4E50-98BA-E47CEBF5DC57Q37831902-5DBD1167-59C6-482C-B36C-80E0B809EEEAQ37933440-A1DED2D1-4AC1-487A-85AD-323B238F8CEBQ38097544-E4AD1181-7799-4C1D-B388-E750BEB9D722Q38118167-06C20BCE-9B5A-4DDA-93B3-040D0886A94EQ38371659-F368D7DF-C4A9-4593-98B8-04F4099EC54AQ38687541-6BD036B4-1053-42F5-9589-634EA7CC4080Q38782141-276FD8DD-1886-4C7F-A6C1-7D3E67AE2535Q38822525-CE6FB300-2DA4-4883-ADBA-67CB8513985DQ39205715-091665E6-10F1-45C3-A64A-1D6069FF3244Q40438904-2444CBE8-7B63-4EFD-9D88-A50C0F116906Q40513679-1A076452-2FE0-4796-826D-0A4AD1BE179BQ40695241-6B8EB20D-ED56-4C6A-BD56-365ACF6E14A1Q41076269-F386CBC4-0B80-4964-A09F-54548DB1CBBCQ41355129-BD0465BB-54EB-4C21-BF73-954DEEFFC8D0Q41561637-B15C581C-BA22-43D6-AF27-CBCF93A0BA10Q41687154-03BDFA16-9D26-4206-952E-B9923BD5C119
P2860
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Excellent survival following t ...... AB/LMB 96 international study.
@en
Excellent survival following t ...... AB/LMB 96 international study.
@nl
type
label
Excellent survival following t ...... AB/LMB 96 international study.
@en
Excellent survival following t ...... AB/LMB 96 international study.
@nl
prefLabel
Excellent survival following t ...... AB/LMB 96 international study.
@en
Excellent survival following t ...... AB/LMB 96 international study.
@nl
P2093
P2860
P1476
Excellent survival following t ...... AB/LMB 96 international study.
@en
P2093
Anne Auperin
Anne Lambilliote
Catherine Patte
Claire Weston
FAB LMB96 International Study Committee
Keith McCarthy
Marie-José T Lacombe
Mary Gerrard
Mitchell S Cairo
Richard Sposto
P2860
P304
P356
10.1111/J.1365-2141.2008.07144.X
P407
P577
2008-03-26T00:00:00Z